Detection of hepatocellular cancer during screening of 1125 patients with chronic hepatitis virus infection.
Izzo
F
F
G. Pascale National Cancer Institute, Naples, Italy.
Cremona
F
F
Ruffolo
F
F
Palaia
R
R
Parisi
V
V
Curley
S
S
D001706:Biopsy; D006528:Carcinoma, Hepatocellular / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology; D002908:Chronic Disease; D016174:Hepacivirus / Q000276:immunology; D006509:Hepatitis B / Q000097:blood / Q000150:complications / Q000175:diagnosis*; D006510:Hepatitis B Antibodies / Q000032:analysis; D006515:Hepatitis B virus / Q000276:immunology; D006526:Hepatitis C / Q000097:blood / Q000150:complications / Q000175:diagnosis*; D018937:Hepatitis C Antibodies / Q000032:analysis; D006521:Hepatitis, Chronic / Q000097:blood / Q000175:diagnosis; D006801:Humans; D015994:Incidence; D008103:Liver Cirrhosis / Q000097:blood / Q000150:complications / Q000175:diagnosis; D008113:Liver Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology; D008279:Magnetic Resonance Imaging; D008403:Mass Screening / Q000379:methods*; D011446:Prospective Studies; D015996:Survival Rate; D014057:Tomography, X-Ray Computed; D000509:alpha-Fetoproteins / Q000378:metabolism
D006510:Hepatitis B Antibodies; D018937:Hepatitis C Antibodies; D000509:alpha-Fetoproteins